Research indicates that 90% of osteogenesis imperfecta (OI) cases result from pathogenic variants in the COL1A1 or COL1A2 genes, which encode the α1 and α2 chains of type I collagen, respectively. The gene discussed is COL1A2; the disease is osteogenesis imperfecta.